VOYA INVESTMENT MANAGEMENT LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$55,411
-70.3%
43,631
-23.1%
0.00%
Q2 2023$186,566
-91.0%
56,707
-88.7%
0.00%
-100.0%
Q1 2023$2,063,872
+22.8%
502,159
+75.0%
0.00%
+50.0%
Q4 2022$1,681,198
+3.9%
286,894
+19.9%
0.00%0.0%
Q3 2022$1,617,560
+957.2%
239,284
+621.3%
0.00%
Q2 2022$153,000
+45.7%
33,172
+26.0%
0.00%
Q1 2022$105,000
-36.0%
26,3260.0%0.00%
Q4 2021$164,000
-34.1%
26,326
-0.4%
0.00%
Q3 2021$249,000
-30.6%
26,4380.0%0.00%
-100.0%
Q2 2021$359,000
-3.2%
26,438
+15.2%
0.00%0.0%
Q1 2021$371,000
-39.6%
22,950
-0.5%
0.00%0.0%
Q4 2020$614,000
+83.8%
23,060
+28.5%
0.00%0.0%
Q3 2020$334,000
-10.2%
17,939
+12.7%
0.00%0.0%
Q2 2020$372,000
+235.1%
15,916
-16.1%
0.00%
Q1 2020$111,000
+1.8%
18,9670.0%0.00%
Q4 2019$109,000
+419.0%
18,967
+45.1%
0.00%
Q3 2019$21,000
-60.4%
13,0690.0%0.00%
Q2 2019$53,00013,0690.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders